tiprankstipranks

Telo Genomics Earns Key CLIA Certification

Story Highlights
Telo Genomics Earns Key CLIA Certification

Telo Genomics Corp (TSE:TELO) has released an update.

Confident Investing Starts Here:

Telo Genomics Corp has achieved a significant milestone by obtaining a CLIA certification, enabling the company to commercialize its TeloView diagnostic tests for oncology in the USA and internationally. This designation will bolster its partnerships within the diagnostic industry, especially in the area of multiple myeloma where its TeloView tests can play a crucial role.

For further insights into TSE:TELO stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App